World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
41
Citations
5891
World Ranking
4917
National Ranking
235

Pierre Delobel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pierre Delobel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 171 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pierre Delobel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Delobel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 41 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?

    Jean Michel Mansuy;Marine Dutertre;Catherine Mengelle;Camille Fourcade

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Zika virus in semen and spermatozoa

    Jean Michel Mansuy;Elsa Suberbielle;Sabine Chapuy-Regaud;Catherine Mengelle

  • Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals

    Maud Mavigner;Michelle Cazabat;Martine Dubois;Fatima-Ezzahra L’Faqihi

  • HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy

    Maud Mavigner;Pierre Delobel;Pierre Delobel;Michelle Cazabat;Martine Dubois

  • R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.

    Pierre Delobel;Karine Sandres-Sauné;Michelle Cazabat;Christophe Pasquier

  • Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.

    Stéphanie Raymond;Pierre Delobel;Maud Mavigner;Michelle Cazabat

  • Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens.

    Jean Michel Mansuy;Catherine Mengelle;Christophe Pasquier;Sabine Chapuy-Regaud

  • Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies

    Pierre Delobel;Marie-Thérèse Nugeyre;Michelle Cazabat;Christophe Pasquier

  • Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART

    Pierre Delobel;Karine Sandres-Sauné;Michelle Cazabat;Fatima-Ezzahra L'Faqihi

  • CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression.

    Stéphanie Raymond;Pierre Delobel;Maud Mavigner;Michelle Cazabat

  • HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.

    Nawal Ben Haij;Rémi Planès;Kaoutar Leghmari;Manutea Serrero

  • Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage

    Stéphanie Raymond;Pierre Delobel;Pierre Delobel;Maud Mavigner;Michelle Cazabat

  • Hepatitis E virus replication in human intestinal cells.

    Olivier Marion;Sebastien Lhomme;Manon Nayrac;Martine Dubois

  • Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

    Clotilde Allavena;Matthieu Hanf;Matthieu Hanf;David Rey;Claudine Duvivier

  • Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers.

    Marion Migueres;Catherine Mengelle;Chloé Dimeglio;Alain Didier

  • Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV

    Guillaume Martin-Blondel;Guillaume Martin-Blondel;Pierre Delobel;Pierre Delobel;Antoine Blancher;Patrice Massip

  • Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men.

    Laurent Cotte;Eric Cua;Jacques Reynes;François Raffi;François Raffi

  • Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

    L. Papst;B. Beović;B. Beović;C. Pulcini;E. Durante-Mangoni

  • Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.

    Caroline Besson;Remi Lancar;Sophie Prevot;Michele Algarte-Genin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles